Tokyo, Japan 6/21/17—Analytical instrumentation provider Shimadzu has purchased CRO AlsaChim. Based in France, AlsaChim is focused on stable isotope–labelled compounds, metabolites and pharmaceutical-related substances. No financial details were provided. “With AlsaChim, we have a strong partner in our organization who is able to finalize and validate new application kits and utilize the developments done by EUIC [Shimadzu’s European Innovation Center], and transfer them into ready-to-use products,” said Bjoern-Thoralf Erxleben, senior manager, Analytic Shimadzu Europa. Shimadzu stated that with the addition of stable isotopes and reference methods, the purchase allows it to provide complete kits for its clinical systems, including its LC/MS systems and CLAM-2000 automated sample preparation platform for MS.

The purchase expands Shimadzu’s consumables offerings, especially for MS, in line with the company’s current strategy. AlsaChim has 20 employees, according to a spokesperson for Shimadzu Europe. Shimadzu plans to distribute AlsaChim’s products worldwide.